[ Price : $8.95]
Harvard Medical School professor Jerry Avorn says FDA needs to take a nonbinary approach to some drug approvals with a conditional...[ Price : $8.95]
FDA clears a Phase 3 protocol amendment to allow a time-based analysis of Glycomimetics uproleselan if sufficient survival events ...[ Price : $8.95]
Public Citizens Health Research Group urges FDA to not grant accelerated approval to Sarepta Therapeutics gene therapy SRP-9001 fo...[ Price : $8.95]
FDA clears an American Laboratory Products 510(k) for its Calprotectin Immunoturbidimetric Assay as an aid in diagnosing inflammat...[ Price : $8.95]
FDA issues a partial clinical hold against Mersana Therapeutics clinical trials of UpRi (upifitamab rilsodotin) in platinum-sensit...[ Price : $8.95]
Aldeyra Therapeutics says the Phase 3 INVIGORATE-2 Clinical Trial of 0.25% reproxalap ophthalmic solution in patients with allergi...[ Price : $8.95]
A Florida federal judge stays the states Administrative Procedure Act claims against FDA over the states drug import plan until 11...[ Price : $8.95]
Pfizer says select presentations of its Bicillin L-A and Bicillin C-R prefilled syringes are expected to be depleted later this ye...